🇺🇸 FDA
Patent

US 10653774

Compositions and methods for activating “stimulator of interferon gene”-dependent signalling

granted A61KA61K2039/55511A61K2039/55561

Quick answer

US patent 10653774 (Compositions and methods for activating “stimulator of interferon gene”-dependent signalling) held by The Regents of the University of California expires Mon May 14 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue May 19 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 14 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
9
CPC classes
A61K, A61K2039/55511, A61K2039/55561, A61K31/7084, A61K39/39